Long-term treatment with Pilogel/β-blocker in glaucoma patients

Maas, S. ; Ros, F. E. ; Heer, L. J. ; Keizer, R. J. W.
Springer
Published 1991
ISSN:
1573-2630
Keywords:
β-blocker ; glaucoma ; intra-ocular pressure ; Pilogel
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
Type of Medium:
Electronic Resource
URL:
_version_ 1798296653760823296
autor Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
autorsonst Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
book_url http://dx.doi.org/10.1007/BF00171032
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM19444354X
issn 1573-2630
journal_name International ophthalmology
materialart 1
notes Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
package_name Springer
publikationsjahr_anzeige 1991
publikationsjahr_facette 1991
publikationsjahr_intervall 8009:1990-1994
publikationsjahr_sort 1991
publisher Springer
reference 15 (1991), S. 281-284
schlagwort β-blocker
glaucoma
intra-ocular pressure
Pilogel
search_space articles
shingle_author_1 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
shingle_author_2 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
shingle_author_3 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
shingle_author_4 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
shingle_catch_all_1 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
Long-term treatment with Pilogel/β-blocker in glaucoma patients
β-blocker
glaucoma
intra-ocular pressure
Pilogel
β-blocker
glaucoma
intra-ocular pressure
Pilogel
Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
1573-2630
15732630
Springer
shingle_catch_all_2 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
Long-term treatment with Pilogel/β-blocker in glaucoma patients
β-blocker
glaucoma
intra-ocular pressure
Pilogel
β-blocker
glaucoma
intra-ocular pressure
Pilogel
Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
1573-2630
15732630
Springer
shingle_catch_all_3 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
Long-term treatment with Pilogel/β-blocker in glaucoma patients
β-blocker
glaucoma
intra-ocular pressure
Pilogel
β-blocker
glaucoma
intra-ocular pressure
Pilogel
Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
1573-2630
15732630
Springer
shingle_catch_all_4 Maas, S.
Ros, F. E.
Heer, L. J.
Keizer, R. J. W.
Long-term treatment with Pilogel/β-blocker in glaucoma patients
β-blocker
glaucoma
intra-ocular pressure
Pilogel
β-blocker
glaucoma
intra-ocular pressure
Pilogel
Abstract In a multicentre clinical trial thirteen patients with primary open angle glaucoma or ocular hypertension were followed during at least six months while selfinstilling Pilogel (once daily) and topical β-blocker (twice daily). After six months of combination therapy there was an average decrease in intra-ocular pressure (IOP) of 33.6% 9.5 hours after Pilogel administration and an IOP decrease of 23.4% 22.5 hours after Pilogel administration. With topical β-blocker alone, an average IOP decrease of 15% was measured. Throughout the study we observed in six patients (46.1%) a superficial punctate keratitis which mostly spontaneously cleared. We did not see any serious side-effects after six months of combination therapy.
1573-2630
15732630
Springer
shingle_title_1 Long-term treatment with Pilogel/β-blocker in glaucoma patients
shingle_title_2 Long-term treatment with Pilogel/β-blocker in glaucoma patients
shingle_title_3 Long-term treatment with Pilogel/β-blocker in glaucoma patients
shingle_title_4 Long-term treatment with Pilogel/β-blocker in glaucoma patients
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:55:31.938Z
titel Long-term treatment with Pilogel/β-blocker in glaucoma patients
titel_suche Long-term treatment with Pilogel/β-blocker in glaucoma patients
topic WW-YZ
uid nat_lic_papers_NLM19444354X